Rocket Pharmaceuticals (RCKT) Stock Chart & Stock Price History $10.74 +0.05 (+0.47%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$10.64 -0.11 (-0.98%) As of 01/31/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Rocket Pharmaceuticals Stock Price Performance 5 Day Performance+0.28%1 Month Performance-14.56%3 Month Performance-36.75%6 Month Performance-51.69%Year-To-Date Performance-14.56%1 Year Performance-63.19% Receive RCKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address RCKT Stock Chart for Saturday, February, 1, 2025 RCKT Chart by TradingView Rocket Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/31/2025$10.69$10.74+0.47%$11.15$10.621.82 million shs$979.06 million01/30/2025$10.41$10.69+2.69%$10.79$10.252.11 million shs$974.50 million01/29/2025$10.58$10.41-1.61%$10.66$10.231.16 million shs$948.94 million01/28/2025$10.71$10.58-1.21%$10.74$10.201.13 million shs$964.47 million01/27/2025$10.71$10.71$11.32$10.321.88 million shs$976.32 million01/24/2025$11.08$10.71-3.34%$11.27$10.631.43 million shs$976.32 million01/23/2025$10.48$11.08+5.73%$11.17$10.151.28 million shs$1.01 billion01/22/2025$10.16$10.48+3.15%$10.60$10.071.50 million shs$955.36 million01/21/2025$10.31$10.16-1.45%$10.57$10.101.44 million shs$926.16 million01/20/2025$10.31$10.31$10.61$10.141.73 million shs$939.86 million Get the Latest News and Ratings for RCKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/17/2025$10.21$10.31+0.98%$10.61$10.141.73 million shs$939.86 million01/16/2025$10.88$10.21-6.16%$10.96$10.121.91 million shs$991.79 million01/15/2025$10.43$10.88+4.31%$11.24$10.561.70 million shs$991.79 million01/14/2025$10.73$10.43-2.80%$10.93$10.332.02 million shs$950.77 million01/13/2025$11.14$10.73-3.68%$10.96$10.282.69 million shs$978.12 million01/10/2025$11.79$11.14-5.51%$11.68$10.881.85 million shs$1.02 billion01/09/2025$11.79$11.79$12.65$11.681.41 million shs$1.07 billion01/08/2025$12.55$11.79-6.06%$12.65$11.681.41 million shs$1.07 billion01/07/2025$12.35$12.55+1.62%$13.30$12.401.63 million shs$1.14 billion01/06/2025$12.56$12.35-1.67%$12.94$12.321.16 million shs$1.13 billion01/03/2025$12.72$12.56-1.26%$12.91$12.441.19 million shs$1.14 billion01/02/2025$12.57$12.72+1.19%$13.35$12.601.52 million shs$1.16 billion01/01/2025$12.57$12.57$12.83$12.122.10 million shs$1.15 billion12/31/2024$12.03$12.57+4.49%$12.83$12.122.10 million shs$1.15 billion Related Companies ADMA Stock Chart APLS Stock Chart VKTX Stock Chart RNA Stock Chart PTCT Stock Chart CRNX Stock Chart RYTM Stock Chart AKRO Stock Chart ACLX Stock Chart IMVT Stock Chart Receive RCKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RCKT) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredElon’s ultimate power move?THE ELON SHOCK All of Elon Musk’s strange behavior may soon make sense… and impact the markets in a way no ...Altimetry | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
